-
Mashup Score: 0Nikhil Munshi, M.D on KarMMa in Relapsed Refractory MM #ASCO2020 - 4 year(s) ago
Nikhil C. Munshi, M.D of Dana Farber Cancer Institute discusses the positive results from pivotal KarMMa study of Ide-cel in MM
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Nikhil Munshi, M.D on KarMMa: What Is The CAR-T Cell Expansion In This Study? #ASCO2020 - 4 year(s) ago
Nikhil C. Munshi, M.D of Dana Farber Cancer Institute discusses the positive results from pivotal KarMMa study of Ide-cel in MM
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Nikhil Munshi, M.D on KarMMa Study #ASCO2020 - 4 year(s) ago
Nikhil C. Munshi, M.D of Dana Farber Cancer Institute discusses the positive results from pivotal KarMMa study of Ide-cel in MM
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Marwan Fakih, MD of City of Hope discusses CodeBreak 100: activity of AMG 510, a novel small molecule inhibitor of KRASG12C, in patients with advanced colorectal cancer Read here: https://meetinglibrary.asco.org/record/185490/abstract
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Marwan Fakih, MD on CodeBreak 100: Activity of AMG 510 #ASCO2020 - 4 year(s) ago
Marwan Fakih, MD of City of Hope discusses CodeBreak 100: activity of AMG 510, a novel small molecule inhibitor of KRASG12C, in patients with advanced colorectal cancer
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0First-Line IO Combo Promising in mCRC - 4 year(s) ago
Heinz-Josef Lenz, MD, discusses updated efficacy data in Checkmate 142
Source: www.medpagetoday.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ICOS Antibody Safe in Head and Neck Cancer - 4 year(s) ago
No additional side effects when added to standard of care, says Erminia Massarelli, MD
Source: www.medpagetoday.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Caron Jacobson, MD of Dana Farber Cancer Institute @DanaFarber discusses the interim analysis of zuma-5 presented at this year’s virtual ASCO. Read here: https://meetinglibrary.asco.org/record/186013/abstract
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Huma Q. Rana, MD on Genetic Counseling: Does Clinical Care Change? #ASCO2020 @DanaFarber - 4 year(s) ago
Huma Q. Rana, MD of Dana Farber Cancer Institute @DanaFarber discusses a randomized controlled trial of video-education or in-person genetic counseling for men with prostate cancer (ProGen).
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Huma Q. Rana, MD on Genetic Counseling: What's In The Video Education? #ASCO2020 @DanaFarber - 4 year(s) ago
Huma Q. Rana, MD of Dana Farber Cancer Institute @DanaFarber discusses a randomized controlled trial of video-education or in-person genetic counseling for men with prostate cancer (ProGen).
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Nikhil Munshi, M.D on KarMMa in Relapsed Refractory MM #ASCO2020 https://t.co/1iSNzf2ufh https://t.co/nH04nisknT